MENU
CTOR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Citius Oncology (CTOR) Earnings Date & Reports
Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies... Show more
A.I. Advisor
published Earnings
CTOR is expected to report earnings to rise 66.67% to -10 cents per share on December 17
Q3'26
Est.
$-0.10
Q4'25
Missed
by $0.04
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.01
Q1'25
Missed
by $0.05
The last earnings report on February 13 showed earnings per share of -5 cents, missing the estimate of -1 cents. With 13.09K shares outstanding, the current market capitalization sits at 65.53M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information